Article Versions Notes

Warit S, Rukseree K, Prammananan T, Hongmanee P, Billamas P, Jaitrong S, Chaiprasert A, Jaki BU, Pauli GF, Franzblau SG, et al. In Vitro Activities of Enantiopure and Racemic 1′-Acetoxychavicol Acetate against Clinical Isolates of Mycobacterium tuberculosis. Scientia Pharmaceutica. 2017; 85(3):32. https://doi.org/10.3390/scipharm85030032

Warit, Saradee, Kamolchanok Rukseree, Therdsak Prammananan, Poonpilas Hongmanee, Pamaree Billamas, Sarinya Jaitrong, Angkana Chaiprasert, Birgit U. Jaki, Guido F. Pauli, Scott G. Franzblau, and et al. 2017. "In Vitro Activities of Enantiopure and Racemic 1′-Acetoxychavicol Acetate against Clinical Isolates of Mycobacterium tuberculosis" Scientia Pharmaceutica 85, no. 3: 32. https://doi.org/10.3390/scipharm85030032

Warit, S., Rukseree, K., Prammananan, T., Hongmanee, P., Billamas, P., Jaitrong, S., Chaiprasert, A., Jaki, B. U., Pauli, G. F., Franzblau, S. G., & Palittapongarnpim, P. (2017). In Vitro Activities of Enantiopure and Racemic 1′-Acetoxychavicol Acetate against Clinical Isolates of Mycobacterium tuberculosis. Scientia Pharmaceutica, 85(3), 32. https://doi.org/10.3390/scipharm85030032